Table 1: The correlation of results obtained by; a) SPRCA/HA and Pcat; b) SPRCA/HA and pCTT.
Antibody |
Comparing Methods |
Spearman’s rho |
P-Value |
Strength of Correlation |
Association |
Direction of Correlation |
a) SPRCA/HA and pCAT |
||||||
IgM |
||||||
Anti-A |
HA-pCAT(1+) |
0.45 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
HA-pCAT(1+) |
0.42 |
< 0.05 |
Moderate |
Significant |
Positive |
IgG |
||||||
Anti-A |
SPRCA-pCAT(1+) |
0.52 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
SPRCA- pCAT(1+) |
0.58 |
< 0.05 |
Moderate |
Significant |
Positive |
IgM |
||||||
Anti-A |
HA - pCAT(2+) |
0.43 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
HA - pCAT(2+) |
0.41 |
< 0.05 |
Moderate |
Significant |
Positive |
IgG |
||||||
Anti-A |
SPRCA - pCAT(2+) |
0.51 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
SPRCA- pCAT(2+) |
0.59 |
< 0.05 |
Moderate |
Significant |
Positive |
IgM |
||||||
Anti-A |
HA - pCAT(3+) |
0.43 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
HA- pCAT(3+) |
0.4 |
< 0.05 |
Moderate |
Significant |
Positive |
IgG |
||||||
Anti-A |
SPRCA - pCAT(3+) |
0.53 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
SPRCA- pCAT(3+) |
0.58 |
< 0.05 |
Moderate |
Significant |
Positive |
b) SPRCA/HA and pCTT |
||||||
IgM |
||||||
Anti-A |
HA - pCTT(1+) |
0.41 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
HA- pCTT(1+) |
0.42 |
< 0.05 |
Moderate |
Significant |
Positive |
IgG |
||||||
Anti-A |
SPRCA -pCTT(1+) |
0.47 |
< 0.05 |
Moderate |
Significant |
Positive |
Anti-B |
SPRCA-pCTT(1+) |
0.48 |
< 0.05 |
Moderate |
Significant |
Positive |
CTT: Pre HI treatment performed by CTT; CAT: Pre HI treatment performed by CAT; pCTT: Post HI treatment performed by CTT; pCAT: Post HI treatment performed by CAT